These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 33113472)
1. An update on the global vaccine development for coronavirus. Rab S; Afjal ; Javaid M; Haleem A; Vaishya R Diabetes Metab Syndr; 2020; 14(6):2053-2055. PubMed ID: 33113472 [No Abstract] [Full Text] [Related]
2. Embedding global access in development of future pandemic vaccines. Moon S; Agarwal S; Becker A; Alonso Ruiz A BMJ; 2021 Sep; 374():n2256. PubMed ID: 34544796 [No Abstract] [Full Text] [Related]
3. [COVID-19: Warp Speed vaccines]. Feraoun Y; Maisonnasse P; Le Grand R; Beignon AS Med Sci (Paris); 2021; 37(8-9):759-772. PubMed ID: 34080537 [TBL] [Abstract][Full Text] [Related]
7. Expanding global and national influenza vaccine systems to match the COVID-19 pandemic response. Ruscio BA; Hotez P Vaccine; 2020 Nov; 38(50):7880-7882. PubMed ID: 33121842 [TBL] [Abstract][Full Text] [Related]
8. Covid-19 Vaccines: Several technologies at work. Aggarwal A; Aggarwal R Natl Med J India; 2021; 34(1):1-3. PubMed ID: 34396995 [No Abstract] [Full Text] [Related]
9. Tackling sheepishness about a COVID-19 vaccine for the sake of herd immunity. Gildea F Perspect Public Health; 2020 Nov; 140(6):301-302. PubMed ID: 33222626 [No Abstract] [Full Text] [Related]
10. Emer Cooke. Mullard A Nat Rev Drug Discov; 2021 Jan; 20(1):12-13. PubMed ID: 33311579 [No Abstract] [Full Text] [Related]
11. Impact of COVID-19 on women and children and the need for a gendered approach in vaccine development. Vora KS; Sundararajan A; Saiyed S; Dhama K; Natesan S Hum Vaccin Immunother; 2020 Dec; 16(12):2932-2937. PubMed ID: 33175602 [TBL] [Abstract][Full Text] [Related]
12. Arrival of Covid-19 vaccine cheers Alaska hospital's staff. Traynor K Am J Health Syst Pharm; 2021 Feb; 78(5):367-368. PubMed ID: 33605990 [No Abstract] [Full Text] [Related]
13. Building Confidence to CONVINCE. Larson HJ; Lee N; Rabin KH; Rauh L; Ratzan SC J Health Commun; 2020 Oct; 25(10):838-842. PubMed ID: 33719882 [TBL] [Abstract][Full Text] [Related]
14. Status of vaccine development for COVID-19. Mendes A Br J Community Nurs; 2020 Dec; 25(12):620-621. PubMed ID: 33275511 [No Abstract] [Full Text] [Related]
15. Cancer and COVID-19 vaccines: a complex global picture. Yusuf A; Sarfati D; Booth CM; Pramesh CS; Lombe D; Aggarwal A; Bhoo-Pathy N; Tsunoda A; Vanderpuye V; Kutluk T; Sullivan A; Mukherji D; Mutebi M; van Hemelrijck M; Sullivan R; Lancet Oncol; 2021 Jun; 22(6):749-751. PubMed ID: 33930324 [No Abstract] [Full Text] [Related]
16. Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development. Kahn JP; Henry LM; Mastroianni AC; Chen WH; Macklin R Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28538-28542. PubMed ID: 33122444 [No Abstract] [Full Text] [Related]
17. Global covid-19 vaccine rollout and safety surveillance-how to keep pace. Lo Re V; Klungel OH; Chan KA; Panozzo CA; Zhou W; Winterstein AG BMJ; 2021 Jun; 373():n1416. PubMed ID: 34144957 [No Abstract] [Full Text] [Related]
19. COVID-19 and global equity for health: The good, the bad, and the wicked. Geng EH; Reid MJA; Goosby E; Abdool-Karim Q PLoS Med; 2021 Oct; 18(10):e1003797. PubMed ID: 34597296 [TBL] [Abstract][Full Text] [Related]
20. Allocating Vaccines in a Pandemic: The Ethical Dimension. Wu JH; John SD; Adashi EY Am J Med; 2020 Nov; 133(11):1241-1242. PubMed ID: 32653419 [No Abstract] [Full Text] [Related] [Next] [New Search]